Business / Finance

RSS

Sanofi-aventis enters definitive agreement to acquire Genzyme

Sanofi-aventis and Genzyme Corporation announced today that they have entered into a definitive agreement under which sanofi-aventis is to acquire Genzyme for $74.00 per share in cash, or approximately $20.1 billion.

16 Feb 2011

Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide

Sanofi-aventis and Sunnybrook Health Sciences Centre announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.

16 Feb 2011

Fibrocell Science sells $7.8 million Series D convertible preferred stock

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that between December 8, 2010 and February 9, 2011 it entered into agreements with certain accredited investors, pursuant to which the Company sold to the purchasers in the aggregate approximately $7.8 million of the Company's Series D convertible preferred stock, which is convertible into shares of common stock at a conversion price of $0.50 per share.

16 Feb 2011

Thermo Fisher Scientific extends tender offer for Dionex

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation for $118.50 per share in cash has been extended and will now expire at 12:00 midnight, New York City time, at the end of Thursday, April 7, 2011, unless further extended.

From Thermo Fisher Scientific Inc. 16 Feb 2011

Orabrush closes $2.5 million investment round

Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.

16 Feb 2011

Gen-Probe board authorizes $150 million stock repurchase

Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.

16 Feb 2011

Orthofix 2010 net sales increase 3% to $564.4 million

Orthofix International N.V. today announced its results for the fourth quarter and year ended December 31, 2010.

16 Feb 2011

Benchmark signs definitive agreement to form $890 million partnership with Health Care REIT

Benchmark Senior Living, the leading provider of senior living services in the Northeast, announced today that it has signed a definitive agreement to form an $890 million partnership with Health Care REIT, Inc., an S&P 500 company that invests across the full spectrum of senior housing and health care real estate.

16 Feb 2011

UMB achieves 35% increase in health spending accounts

UMB Healthcare Services, a division of UMB Financial Corporation, announced today that it has achieved a 35 percent increase in the number of its health spending accounts.

15 Feb 2011

Prime Health Services acquires Applied Metrics

Prime Health Services, one of the nation's largest workers' compensation, group health, and first party auto liability PPO networks, is pleased to announce it has acquired majority interest in Applied Metrics.

15 Feb 2011

Cynosure 2010 fourth quarter revenues increase 16% to $22.3 million

Cynosure, Inc. today announced financial results for the three months and year ended December 31, 2010.

15 Feb 2011

China Jo-Jo Drugstores revenues increase 20.9% to $18.0 million

China Jo-Jo Drugstores, which operates retail pharmacies in the People's Republic of China, reported financial results for the third quarter and nine-month period of fiscal 2011 ended December 31, 2010.

15 Feb 2011

Apricus Bio awards Neopharm exclusive rights to market and sell Vitaros in Israel and Palestinian Territories

Apricus Biosciences, Inc., announced today that it has entered into a licensing agreement granting Neopharm Group the exclusive rights to market and sell Vitaros®, Apricus Bio's treatment for erectile dysfunction ("ED") and, when and if available, its formulation for the treatment of premature ejaculation ("PE"), in Israel and the Palestinian Territories of the Gaza Strip and the West Bank.

15 Feb 2011

Sonoma announces closing of $22 million Series D financing

Sonoma Orthopedic Products announced that it has closed a $22 million Series D financing round led by Ascension Health Ventures (AHV). Also participating in the round were Split Rock Partners, Legacy Life Sciences, EDF Ventures, MedVenture Associates, DFJ InCube Ventures, Emergent Medical Partners, and Asset Management Partners.

14 Feb 2011

Cantel Medical acquires ConFirm's sterilization monitoring business

CANTEL MEDICAL CORP., through its Crosstex International subsidiary, has further expanded its infection prevention and control business by purchasing the sterilization monitoring business of ConFirm Monitoring Systems, Inc. Based in Denver, Colorado, ConFirm is one of the leading providers of biological monitoring services in North America.

14 Feb 2011

Australian Department of Defence, CSC sign contract to develop, implement JeHDI system for ADF

In a press conference today with the Australian Department of Defence, CSC announced it has signed a five-year information technology contract to develop and implement an electronic health information system for the Australian Defence Force known as the Joint eHealth Data and Information system.

14 Feb 2011

Swisher Hygiene enters definitive agreement to acquire Choice Environmental Services

Swisher Hygiene Inc., a leading provider of essential hygiene and sanitation products and services, today announced that it has entered into a definitive agreement to acquire Choice Environmental Services, a Fort Lauderdale, Florida-based residential and commercial solid waste services company, by way of a statutory merger involving a wholly-owned subsidiary of Swisher Hygiene.

14 Feb 2011

bioMD makes offer for Allied Medical

bioMD Limited (ASX: BOD), a company with assets in regenerative tissue engineering technologies today announced that it has made an offer to buy all of the shares in Allied Medical Limited (Allied), a public unlisted company that specialises in the sales, distribution and commercialisation of medical technologies.

14 Feb 2011

Microbix first quarter revenues decrease 34% to $812,694

Microbix Biosystems Inc., a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and livestock semen sexing, in addition to a core business of virology products, today reported financial results for the first quarter of fiscal 2011. For the quarter ended December 31, 2010, Microbix reported revenues of $812,694, a 34% decrease from $1,226,538 for the same period in 2009.

14 Feb 2011

K-V Pharmaceutical to raise $32 million through private placement

K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.

14 Feb 2011